Variable manifestation in natural killer cell leukaemia
Summary Natural killer (NK) cell leukaemias are a relatively rare group of haematological disorders, now entitled in the T/NK lymphoproliferative disorders in the new WHO classification. Recent studies have clarified their biological and clinical manifestation gradually. However, some cases with NK...
Gespeichert in:
Veröffentlicht in: | Clinical and laboratory haematology 2003-08, Vol.25 (4), p.239-245 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 245 |
---|---|
container_issue | 4 |
container_start_page | 239 |
container_title | Clinical and laboratory haematology |
container_volume | 25 |
creator | Kuroda, J. Kimura, S. Kobayashi, Y. Jyoko, N. Kamitsuji, Y. Murotani, Y. Fukuda, W. Akaogi, T. Hayashi, H. Yoshikawa, T. Maekawa, T. |
description | Summary
Natural killer (NK) cell leukaemias are a relatively rare group of haematological disorders, now entitled in the T/NK lymphoproliferative disorders in the new WHO classification. Recent studies have clarified their biological and clinical manifestation gradually. However, some cases with NK malignancies still remain difficult to diagnose and differentiate into their subtypes in the absence of a distinct diagnostic hallmark, especially at initial presentation. We describe herein five patients with NK leukaemias with respect to the clinical, cytological, immunological and cytogenetic characteristics, varied among each case. Cytologically, two aggressive NK cell leukaemia/lymphoma (ANKL/L) cases were a morphologically hypogranular variant form. Clinically, one with ANKL/L was presented as haemophagocytic syndrome without leukaemic infiltration. Systemic chemotherapy resulted in complete remission in one ANKL/L and two blastic NK cell leukaemia/lymphoma (BNKL/L) patients; however, a good long‐term outcome was achieved in only one CD4‐positive BNKL/L patient with allogenic bone marrow transplantation. Cytogenetic analysis revealed that recurrent chromosomal aberration was rare; however, two had aberrations at 10p11 and 11q13. From these findings, we conclude that comprehensive individual studies should be carried out in these patients to obtain a correct diagnosis and to design an optimal therapeutic approach. |
doi_str_mv | 10.1046/j.1365-2257.2003.00528.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73522277</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73522277</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3868-17e9c24d4677d6ea460e38c5076e8957887c37766fab769acd9440f2a505ee003</originalsourceid><addsrcrecordid>eNpFkE1P20AQhlcIVFLoX0C-wM3ufs_6wKEKLQFFrZD4OK4mzljaZO1Qb6yGf1-7SeE0I83zjmYexjLBC8G1_boqhLIml9JAITlXBedGumJ3xCbvg2M24UKLvHRGn7LPKa04F0oAfGKnQrqSC6smDJ6xC7iIlDXYhprSFrdh02ahzVrc9h3GbB1ipC6rKMYsUr9GagKes5MaY6Ivh3rGnn58f5zO8vmv27vpt3leKWddLoDKSuqltgBLS6gtJ-Uqw8GSKw04B5UCsLbGBdgSq2WpNa8lGm6Ihs_O2NV-72u3-d0P5_kmpPEUbGnTJw_KSCkBBvDiAPaLhpb-tQsNdm_-_6sDcHkAMFUY6w7bKqQPznCuS-MG7nrP_QmR3j7m3I_q_cqPhv1o2I_q_T_1fufv7uezoRvy-T4f0pZ273ns1t6CAuNfft762YO5mapn4x_VX_1ThBo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73522277</pqid></control><display><type>article</type><title>Variable manifestation in natural killer cell leukaemia</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kuroda, J. ; Kimura, S. ; Kobayashi, Y. ; Jyoko, N. ; Kamitsuji, Y. ; Murotani, Y. ; Fukuda, W. ; Akaogi, T. ; Hayashi, H. ; Yoshikawa, T. ; Maekawa, T.</creator><creatorcontrib>Kuroda, J. ; Kimura, S. ; Kobayashi, Y. ; Jyoko, N. ; Kamitsuji, Y. ; Murotani, Y. ; Fukuda, W. ; Akaogi, T. ; Hayashi, H. ; Yoshikawa, T. ; Maekawa, T.</creatorcontrib><description>Summary
Natural killer (NK) cell leukaemias are a relatively rare group of haematological disorders, now entitled in the T/NK lymphoproliferative disorders in the new WHO classification. Recent studies have clarified their biological and clinical manifestation gradually. However, some cases with NK malignancies still remain difficult to diagnose and differentiate into their subtypes in the absence of a distinct diagnostic hallmark, especially at initial presentation. We describe herein five patients with NK leukaemias with respect to the clinical, cytological, immunological and cytogenetic characteristics, varied among each case. Cytologically, two aggressive NK cell leukaemia/lymphoma (ANKL/L) cases were a morphologically hypogranular variant form. Clinically, one with ANKL/L was presented as haemophagocytic syndrome without leukaemic infiltration. Systemic chemotherapy resulted in complete remission in one ANKL/L and two blastic NK cell leukaemia/lymphoma (BNKL/L) patients; however, a good long‐term outcome was achieved in only one CD4‐positive BNKL/L patient with allogenic bone marrow transplantation. Cytogenetic analysis revealed that recurrent chromosomal aberration was rare; however, two had aberrations at 10p11 and 11q13. From these findings, we conclude that comprehensive individual studies should be carried out in these patients to obtain a correct diagnosis and to design an optimal therapeutic approach.</description><identifier>ISSN: 0141-9854</identifier><identifier>EISSN: 1365-2257</identifier><identifier>DOI: 10.1046/j.1365-2257.2003.00528.x</identifier><identifier>PMID: 12890163</identifier><identifier>CODEN: CLHAD3</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adult ; Aged ; Antigens, CD - analysis ; Antigens, Neoplasm - analysis ; Biological and medical sciences ; Bone marrow transplantation ; CD4 ; Chromosome Aberrations ; Chromosome Banding ; Hematologic and hematopoietic diseases ; Humans ; hypogranular variant ; Immunophenotyping ; Karyotyping ; Killer Cells, Natural - chemistry ; Killer Cells, Natural - pathology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical sciences ; Middle Aged ; natural killer cell leukaemia ; Neoplastic Stem Cells - chemistry ; Neoplastic Stem Cells - pathology ; Peroxidase - analysis ; Phenotype ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology ; Prognosis ; spectral karyotyping</subject><ispartof>Clinical and laboratory haematology, 2003-08, Vol.25 (4), p.239-245</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3868-17e9c24d4677d6ea460e38c5076e8957887c37766fab769acd9440f2a505ee003</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2257.2003.00528.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2257.2003.00528.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15004958$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12890163$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kuroda, J.</creatorcontrib><creatorcontrib>Kimura, S.</creatorcontrib><creatorcontrib>Kobayashi, Y.</creatorcontrib><creatorcontrib>Jyoko, N.</creatorcontrib><creatorcontrib>Kamitsuji, Y.</creatorcontrib><creatorcontrib>Murotani, Y.</creatorcontrib><creatorcontrib>Fukuda, W.</creatorcontrib><creatorcontrib>Akaogi, T.</creatorcontrib><creatorcontrib>Hayashi, H.</creatorcontrib><creatorcontrib>Yoshikawa, T.</creatorcontrib><creatorcontrib>Maekawa, T.</creatorcontrib><title>Variable manifestation in natural killer cell leukaemia</title><title>Clinical and laboratory haematology</title><addtitle>Clin Lab Haematol</addtitle><description>Summary
Natural killer (NK) cell leukaemias are a relatively rare group of haematological disorders, now entitled in the T/NK lymphoproliferative disorders in the new WHO classification. Recent studies have clarified their biological and clinical manifestation gradually. However, some cases with NK malignancies still remain difficult to diagnose and differentiate into their subtypes in the absence of a distinct diagnostic hallmark, especially at initial presentation. We describe herein five patients with NK leukaemias with respect to the clinical, cytological, immunological and cytogenetic characteristics, varied among each case. Cytologically, two aggressive NK cell leukaemia/lymphoma (ANKL/L) cases were a morphologically hypogranular variant form. Clinically, one with ANKL/L was presented as haemophagocytic syndrome without leukaemic infiltration. Systemic chemotherapy resulted in complete remission in one ANKL/L and two blastic NK cell leukaemia/lymphoma (BNKL/L) patients; however, a good long‐term outcome was achieved in only one CD4‐positive BNKL/L patient with allogenic bone marrow transplantation. Cytogenetic analysis revealed that recurrent chromosomal aberration was rare; however, two had aberrations at 10p11 and 11q13. From these findings, we conclude that comprehensive individual studies should be carried out in these patients to obtain a correct diagnosis and to design an optimal therapeutic approach.</description><subject>Adult</subject><subject>Aged</subject><subject>Antigens, CD - analysis</subject><subject>Antigens, Neoplasm - analysis</subject><subject>Biological and medical sciences</subject><subject>Bone marrow transplantation</subject><subject>CD4</subject><subject>Chromosome Aberrations</subject><subject>Chromosome Banding</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>hypogranular variant</subject><subject>Immunophenotyping</subject><subject>Karyotyping</subject><subject>Killer Cells, Natural - chemistry</subject><subject>Killer Cells, Natural - pathology</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>natural killer cell leukaemia</subject><subject>Neoplastic Stem Cells - chemistry</subject><subject>Neoplastic Stem Cells - pathology</subject><subject>Peroxidase - analysis</subject><subject>Phenotype</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology</subject><subject>Prognosis</subject><subject>spectral karyotyping</subject><issn>0141-9854</issn><issn>1365-2257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1P20AQhlcIVFLoX0C-wM3ufs_6wKEKLQFFrZD4OK4mzljaZO1Qb6yGf1-7SeE0I83zjmYexjLBC8G1_boqhLIml9JAITlXBedGumJ3xCbvg2M24UKLvHRGn7LPKa04F0oAfGKnQrqSC6smDJ6xC7iIlDXYhprSFrdh02ahzVrc9h3GbB1ipC6rKMYsUr9GagKes5MaY6Ivh3rGnn58f5zO8vmv27vpt3leKWddLoDKSuqltgBLS6gtJ-Uqw8GSKw04B5UCsLbGBdgSq2WpNa8lGm6Ihs_O2NV-72u3-d0P5_kmpPEUbGnTJw_KSCkBBvDiAPaLhpb-tQsNdm_-_6sDcHkAMFUY6w7bKqQPznCuS-MG7nrP_QmR3j7m3I_q_cqPhv1o2I_q_T_1fufv7uezoRvy-T4f0pZ273ns1t6CAuNfft762YO5mapn4x_VX_1ThBo</recordid><startdate>200308</startdate><enddate>200308</enddate><creator>Kuroda, J.</creator><creator>Kimura, S.</creator><creator>Kobayashi, Y.</creator><creator>Jyoko, N.</creator><creator>Kamitsuji, Y.</creator><creator>Murotani, Y.</creator><creator>Fukuda, W.</creator><creator>Akaogi, T.</creator><creator>Hayashi, H.</creator><creator>Yoshikawa, T.</creator><creator>Maekawa, T.</creator><general>Blackwell Science Ltd</general><general>Blackwell Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200308</creationdate><title>Variable manifestation in natural killer cell leukaemia</title><author>Kuroda, J. ; Kimura, S. ; Kobayashi, Y. ; Jyoko, N. ; Kamitsuji, Y. ; Murotani, Y. ; Fukuda, W. ; Akaogi, T. ; Hayashi, H. ; Yoshikawa, T. ; Maekawa, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3868-17e9c24d4677d6ea460e38c5076e8957887c37766fab769acd9440f2a505ee003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antigens, CD - analysis</topic><topic>Antigens, Neoplasm - analysis</topic><topic>Biological and medical sciences</topic><topic>Bone marrow transplantation</topic><topic>CD4</topic><topic>Chromosome Aberrations</topic><topic>Chromosome Banding</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>hypogranular variant</topic><topic>Immunophenotyping</topic><topic>Karyotyping</topic><topic>Killer Cells, Natural - chemistry</topic><topic>Killer Cells, Natural - pathology</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>natural killer cell leukaemia</topic><topic>Neoplastic Stem Cells - chemistry</topic><topic>Neoplastic Stem Cells - pathology</topic><topic>Peroxidase - analysis</topic><topic>Phenotype</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology</topic><topic>Prognosis</topic><topic>spectral karyotyping</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kuroda, J.</creatorcontrib><creatorcontrib>Kimura, S.</creatorcontrib><creatorcontrib>Kobayashi, Y.</creatorcontrib><creatorcontrib>Jyoko, N.</creatorcontrib><creatorcontrib>Kamitsuji, Y.</creatorcontrib><creatorcontrib>Murotani, Y.</creatorcontrib><creatorcontrib>Fukuda, W.</creatorcontrib><creatorcontrib>Akaogi, T.</creatorcontrib><creatorcontrib>Hayashi, H.</creatorcontrib><creatorcontrib>Yoshikawa, T.</creatorcontrib><creatorcontrib>Maekawa, T.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and laboratory haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kuroda, J.</au><au>Kimura, S.</au><au>Kobayashi, Y.</au><au>Jyoko, N.</au><au>Kamitsuji, Y.</au><au>Murotani, Y.</au><au>Fukuda, W.</au><au>Akaogi, T.</au><au>Hayashi, H.</au><au>Yoshikawa, T.</au><au>Maekawa, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Variable manifestation in natural killer cell leukaemia</atitle><jtitle>Clinical and laboratory haematology</jtitle><addtitle>Clin Lab Haematol</addtitle><date>2003-08</date><risdate>2003</risdate><volume>25</volume><issue>4</issue><spage>239</spage><epage>245</epage><pages>239-245</pages><issn>0141-9854</issn><eissn>1365-2257</eissn><coden>CLHAD3</coden><abstract>Summary
Natural killer (NK) cell leukaemias are a relatively rare group of haematological disorders, now entitled in the T/NK lymphoproliferative disorders in the new WHO classification. Recent studies have clarified their biological and clinical manifestation gradually. However, some cases with NK malignancies still remain difficult to diagnose and differentiate into their subtypes in the absence of a distinct diagnostic hallmark, especially at initial presentation. We describe herein five patients with NK leukaemias with respect to the clinical, cytological, immunological and cytogenetic characteristics, varied among each case. Cytologically, two aggressive NK cell leukaemia/lymphoma (ANKL/L) cases were a morphologically hypogranular variant form. Clinically, one with ANKL/L was presented as haemophagocytic syndrome without leukaemic infiltration. Systemic chemotherapy resulted in complete remission in one ANKL/L and two blastic NK cell leukaemia/lymphoma (BNKL/L) patients; however, a good long‐term outcome was achieved in only one CD4‐positive BNKL/L patient with allogenic bone marrow transplantation. Cytogenetic analysis revealed that recurrent chromosomal aberration was rare; however, two had aberrations at 10p11 and 11q13. From these findings, we conclude that comprehensive individual studies should be carried out in these patients to obtain a correct diagnosis and to design an optimal therapeutic approach.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>12890163</pmid><doi>10.1046/j.1365-2257.2003.00528.x</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0141-9854 |
ispartof | Clinical and laboratory haematology, 2003-08, Vol.25 (4), p.239-245 |
issn | 0141-9854 1365-2257 |
language | eng |
recordid | cdi_proquest_miscellaneous_73522277 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adult Aged Antigens, CD - analysis Antigens, Neoplasm - analysis Biological and medical sciences Bone marrow transplantation CD4 Chromosome Aberrations Chromosome Banding Hematologic and hematopoietic diseases Humans hypogranular variant Immunophenotyping Karyotyping Killer Cells, Natural - chemistry Killer Cells, Natural - pathology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Middle Aged natural killer cell leukaemia Neoplastic Stem Cells - chemistry Neoplastic Stem Cells - pathology Peroxidase - analysis Phenotype Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology Prognosis spectral karyotyping |
title | Variable manifestation in natural killer cell leukaemia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T21%3A32%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Variable%20manifestation%20in%20natural%20killer%20cell%20leukaemia&rft.jtitle=Clinical%20and%20laboratory%20haematology&rft.au=Kuroda,%20J.&rft.date=2003-08&rft.volume=25&rft.issue=4&rft.spage=239&rft.epage=245&rft.pages=239-245&rft.issn=0141-9854&rft.eissn=1365-2257&rft.coden=CLHAD3&rft_id=info:doi/10.1046/j.1365-2257.2003.00528.x&rft_dat=%3Cproquest_pubme%3E73522277%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73522277&rft_id=info:pmid/12890163&rfr_iscdi=true |